PLANO, Texas, March 7, 2023 /PRNewswire/ — Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, introduces the TRAVELER™ Portal Vein Access Series as the newest addition to its portal vein access product portfolio. The product line is designed to meet the challenging needs of […]
Author: Ken Dropiewski
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System
IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary embolism (“PE”). The data was […]
Restore Medical Announces Successful First-In-Human Preliminary Results of Its CONTRABAND™ System for Symptomatic Systolic Heart Failure Patients
OR YEHUDA, Israel, March 7, 2023 /PRNewswire/ — Restore Medical Ltd, a privately held medical device company, has successfully completed enrollment of the First In Human clinical study with its CONTRABAND™ device. The world’s first and only Pulmonary Artery Banding (PAB) transcatheter implant is designed to treat heart failure with reduced ejection fraction (HFrEF) and […]
Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial
Study will evaluate THERMOCOOL SMARTTOUCH™ SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation Irvine, CA – March 7, 2023 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced […]
Neovasc Shareholders Approve Acquisition by Shockwave Medical
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as defined below) have approved the previously-announced acquisition of all […]
Powerful Medical Launches PMcardio in the UK, Empowering Healthcare Professionals to Diagnose and Treat Cardiovascular Diseases with AI
LONDON, March 07, 2023 (GLOBE NEWSWIRE) — Powerful Medical is thrilled to announce the release of PMcardio, a revolutionary clinical assistant powered by artificial intelligence in the United Kingdom. The unique medical device in the form of a smartphone application empowers healthcare professionals to diagnose and treat 38 cardiovascular diseases from […]
Amarin Announces Board Departures
DUBLIN, Ireland and BRIDGEWATER. N.J., March 06, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that, in the interest of the Company to avoid further proxy contests, all seven independent non-Sarissa board members: Adam Berger, Erin Enright, Geraldine Murphy, Kristine Peterson, Dr. Murray […]
Medtronic Evolut™ TAVR platform shows excellent valve performance and durability in low-risk aortic stenosis patients
ACC.23/WCC Late-Breaking Clinical Trial: Evolut™ is only TAVR to show excellent outcomes in low-risk patients at 3 years Medtronic today announced three-year data from the Evolut Low Risk Trial, demonstrating the Medtronic EvolutTM transcatheter aortic valve replacement (TAVR) System had numerically better clinical outcomes and significantly better hemodynamic valve performance than […]
New Data Show Superiority of Abbott’s TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation
Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR) Findings show TriClip, an investigational device in the U.S. to treat a leaky […]
Results from Benefit of Microcor in Acute Decompensated Heart Failure (BMAD) Trial Presented as ACC.23/WCC Late-Breaking Clinical Trial
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that results from the Benefit of Microcore in Acute Decompensated Heart Failure (BMAD) Trial were presented today by Dr. John Boehmer, MD, of Penn State Health Milton S. Hershey Medical Center and the […]



